245 related articles for article (PubMed ID: 9200454)
1. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.
Kitanaka A; Ito C; Coustan-Smith E; Campana D
J Immunol; 1997 Jul; 159(1):184-92. PubMed ID: 9200454
[TBL] [Abstract][Full Text] [Related]
2. CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain.
Kitanaka A; Suzuki T; Ito C; Nishigaki H; Coustan-Smith E; Tanaka T; Kubota Y; Campana D
J Immunol; 1999 Feb; 162(4):1952-8. PubMed ID: 9973464
[TBL] [Abstract][Full Text] [Related]
3. CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase.
Silvennoinen O; Nishigaki H; Kitanaka A; Kumagai M; Ito C; Malavasi F; Lin Q; Conley ME; Campana D
J Immunol; 1996 Jan; 156(1):100-7. PubMed ID: 8598449
[TBL] [Abstract][Full Text] [Related]
4. CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene.
Kitanaka A; Ito C; Nishigaki H; Campana D
Blood; 1996 Jul; 88(2):590-8. PubMed ID: 8695807
[TBL] [Abstract][Full Text] [Related]
5. Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgammaII receptors in human myeloid cell lines.
Inoue S; Kontani K; Tsujimoto N; Kanda Y; Hosoda N; Hoshino S; Hazeki O; Katada T
J Immunol; 1997 Dec; 159(11):5226-32. PubMed ID: 9548461
[TBL] [Abstract][Full Text] [Related]
6. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression.
Lund FE; Yu N; Kim KM; Reth M; Howard MC
J Immunol; 1996 Aug; 157(4):1455-67. PubMed ID: 8759726
[TBL] [Abstract][Full Text] [Related]
7. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.
Li X; Sandoval D; Freeberg L; Carter RH
J Immunol; 1997 Jun; 158(12):5649-57. PubMed ID: 9190913
[TBL] [Abstract][Full Text] [Related]
8. The signaling activity of murine CD19 is regulated during cell development.
Krop I; Shaffer AL; Fearon DT; Schlissel MS
J Immunol; 1996 Jul; 157(1):48-56. PubMed ID: 8683154
[TBL] [Abstract][Full Text] [Related]
9. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM
Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205
[TBL] [Abstract][Full Text] [Related]
10. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
[TBL] [Abstract][Full Text] [Related]
11. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
[TBL] [Abstract][Full Text] [Related]
12. Association of phosphatidylinositol 3-kinase with the proto-oncogene product Cbl upon CD38 ligation by a specific monoclonal antibody in THP-1 cells.
Matsuo T; Hazeki K; Tsujimoto N; Inoue S; Kurosu H; Kontani K; Hazeki O; Ui M; Katada T
FEBS Lett; 1996 Nov; 397(1):113-6. PubMed ID: 8941725
[TBL] [Abstract][Full Text] [Related]
13. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
Bouillie S; Barel M; Frade R
J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
[TBL] [Abstract][Full Text] [Related]
14. Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages.
Funaro A; De Monte LB; Dianzani U; Forni M; Malavasi F
Eur J Immunol; 1993 Oct; 23(10):2407-11. PubMed ID: 8405040
[TBL] [Abstract][Full Text] [Related]
15. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
[TBL] [Abstract][Full Text] [Related]
16. CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells.
Roifman CM; Ke S
Biochem Biophys Res Commun; 1993 Jul; 194(1):222-5. PubMed ID: 7687428
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of interleukin 4-induced down-regulation of CD38 on human B cells.
Shubinsky G; Schlesinger M
Cell Immunol; 1996 Oct; 173(1):87-95. PubMed ID: 8871604
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
[TBL] [Abstract][Full Text] [Related]
19. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
20. Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells.
Weng WK; Shah N; O'Brien D; Van Ness B; LeBien TW
J Immunol; 1997 Dec; 159(11):5502-8. PubMed ID: 9548490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
